Cargando…

Shorter & cheaper regimen to treat multidrug-resistant tuberculosis: A new hope

Detalles Bibliográficos
Autores principales:	Prasad, Rajendra, Gupta, Nikhil, Banka, Amitabh
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications & Media Pvt Ltd 2017
Materias:	Viewpoint
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5793463/ https://www.ncbi.nlm.nih.gov/pubmed/29355135 http://dx.doi.org/10.4103/ijmr.IJMR_1704_16

Ejemplares similares

Rapid diagnosis and shorter regimen for multidrug-resistant tuberculosis: A priority to improve treatment outcome
por: Prasad, Rajendra, et al.
Publicado: (2017)

Multidrug-resistant tuberculosis/rifampicin-resistant tuberculosis: Principles of management
por: Prasad, Rajendra, et al.
Publicado: (2018)

Can Pan-TB shorter regimens be a promising hope for ending TB in India by 2025 in ongoing COVID-19 era?
por: Prasad, Rajendra, et al.
Publicado: (2022)

Making the Case for All-Oral, Shorter Regimens for Children with Drug-Resistant Tuberculosis
por: Patankar, Sayalee, et al.
Publicado: (2023)

2025 too short time to eliminate tuberculosis from India
por: Prasad, Rajendra, et al.
Publicado: (2017)

Outcomes with a shorter multidrug-resistant tuberculosis regimen from Karakalpakstan, Uzbekistan
por: du Cros, Philipp, et al.
Publicado: (2021)

Initial resistance to companion drugs should not be considered an exclusion criterion for the shorter multidrug-resistant tuberculosis treatment regimen
por: Lempens, Pauline, et al.
Publicado: (2020)

Effectiveness and Safety of a Shorter Treatment Regimen in a Setting with a High Burden of Multidrug-Resistant Tuberculosis
por: Trubnikov, Aleksandr, et al.
Publicado: (2021)

Effectiveness and safety of fully oral modified shorter treatment regimen for multidrug-resistant tuberculosis in Georgia, 2019–2020
por: Avaliani, Teona, et al.
Publicado: (2021)

Drug-resistant tuberculosis: Progress towards shorter and safer regimens
por: Saravu, Kavitha, et al.
Publicado: (2019)

Eligibility for shorter treatment of multidrug-resistant tuberculosis in the European Union
por: van der Werf, Marieke J., et al.
Publicado: (2017)

Treatment-shortening regimens for tuberculosis: updates and future priorities
por: Saluzzo, Francesca, et al.
Publicado: (2023)

Cleaner is cheaper
por: Narang, R K
Publicado: (2006)

Comparative effectiveness of individualized longer and standardized shorter regimens in the treatment of multidrug resistant tuberculosis in a high burden country
por: Wahid, Abdul, et al.
Publicado: (2022)

Yaws Eradication: Facing Old Problems, Raising New Hopes
por: Rinaldi, Andrea
Publicado: (2012)

High success and low recurrence with shorter treatment regimen for multidrug-resistant TB in Nepal
por: Koirala, S., et al.
Publicado: (2021)

Towards all-oral and shorter treatment regimens for drug-resistant tuberculosis
por: Weyer, Karin, et al.
Publicado: (2018)

Better programmatic outcome with the shorter regimen for the treatment of multidrug-resistant tuberculosis (MDR-TB) in Guinea: A retrospective cohort study
por: Hassane-Harouna, Souleymane, et al.
Publicado: (2020)

Ferroportin and hepcidin: a new hope in diagnosis, prognosis, and therapy for breast cancer
por: Pogribny, Igor P
Publicado: (2010)

A rare case of sarcoidosis with necrotizing mediastinal lymphadenitis misdiagnosed as multidrug-resistant tuberculosis (MDR- TB)
por: Prasad, Rajendra, et al.
Publicado: (2022)

Cheaper Institutional Care
por: Stephens, H. Freize
Publicado: (1933)

The Cheaper Cinchona Alkaloids
Publicado: (1875)

The Cheaper Cinchona Alkaloids
por: Whitmire, Jas. S.
Publicado: (1875)

Blockchain in Health Care: Hope or Hype?
por: El-Gazzar, Rania, et al.
Publicado: (2020)

Injectables’ key role in rifampicin-resistant tuberculosis shorter treatment regimen outcomes
por: Decroo, Tom, et al.
Publicado: (2020)

Regimens to treat multidrug-resistant tuberculosis: past, present and future perspectives
por: Pontali, Emanuele, et al.
Publicado: (2019)

High Levels of Treatment Success and Zero Relapse in Multidrug-Resistant Tuberculosis Patients Receiving a Levofloxacin-Based Shorter Treatment Regimen in Vietnam
por: Anh, Le T. N., et al.
Publicado: (2020)

Robotic Assisted Percutaneous Coronary Intervention: Hype or Hope?
por: Chakravartti, Jaidip, et al.
Publicado: (2019)

Cost Effectiveness of a Shorter Moxifloxacin Based Regimen for Treating Drug Sensitive Tuberculosis in India
por: Muniyandi, Malaisamy, et al.
Publicado: (2022)

Multidrug-Resistant Tuberculosis in Child Successfully Treated with 9-Month Drug Regimen
por: Achar, Jay, et al.
Publicado: (2015)

High hopes for RANKL: will the mouse model live up to its promise?
por: Tanos, Tamara, et al.
Publicado: (2011)

Moxifloxacin concentration correlate with QTc interval in rifampicin-resistant tuberculosis patients on shorter treatment regimens
por: Kusmiati, Tutik, et al.
Publicado: (2022)

Identifying patients with multidrug-resistant tuberculosis who may benefit from shorter durations of treatment
por: Winters, Nicholas, et al.
Publicado: (2023)

30 years of observations and hopes for faster progress on promoting the status of women in science
por: Randolph, Gwendalyn J.
Publicado: (2021)

HOPES: An Integrative Digital Phenotyping Platform for Data Collection, Monitoring, and Machine Learning
por: Wang, Xuancong, et al.
Publicado: (2021)

Thorium: energy cheaper than coal
por: Hargraves, Robert
Publicado: (2013)

“Piggy-Backing” on Diagnostic Platforms Brings Hope to Neglected Diseases: The Case of Sleeping Sickness
por: Ndung'u, Joseph Mathu, et al.
Publicado: (2010)

HIV-1 resistance patterns to integrase inhibitors in Chilean patients with virological failure on raltegravir-containing regimens
por: Ferrer, Pablo, et al.
Publicado: (2020)

With Great Hopes Come Great Expectations: Access and Adoption Issues Associated With COVID-19 Vaccines
por: Su, Zhaohui, et al.
Publicado: (2021)

Antimicrobial peptides: new hope in the war against multidrug resistance
por: Mwangi, James, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_lrigf4967p56p0l2tf4t9c42il